Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Soluble DPP4 induces inflammation and proliferation of human smooth muscle cells via protease-activated receptor 2
Nina Wronkowitz, Sven W. Görgens, Tania Romacho, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2014) Vol. 1842, Iss. 9, pp. 1613-1621
Open Access | Times Cited: 138

Showing 1-25 of 138 citing articles:

DPP4 in diabetes
Diana Röhrborn
Frontiers in Immunology (2015) Vol. 6
Open Access | Times Cited: 387
Dipeptidyl peptidase-4 (DPP4) inhibition in COVID-19
Sebastiano Bruno Solerte, Antonio Di Sabatino, Massimo Galli, et al.
Acta Diabetologica (2020) Vol. 57, Iss. 7, pp. 779-783
Open Access | Times Cited: 198
Dipeptidyl Peptidase 4 Distribution in the Human Respiratory Tract
David K. Meyerholz, Allyn M. Lambertz, Paul B. McCray
American Journal Of Pathology (2015) Vol. 186, Iss. 1, pp. 78-86
Open Access | Times Cited: 167
Elevated hepatic DPP4 activity promotes insulin resistance and non-alcoholic fatty liver disease
Christian Baumeier, Luisa Schlüter, Sophie Saussenthaler, et al.
Molecular Metabolism (2017) Vol. 6, Iss. 10, pp. 1254-1263
Open Access | Times Cited: 131
Inflammation, glucose, and vascular cell damage: the role of the pentose phosphate pathway
Concepción Peiró, Tania Romacho, Verónica Azcutia, et al.
Cardiovascular Diabetology (2016) Vol. 15, Iss. 1
Open Access | Times Cited: 120
Circulating Levels of Soluble Dipeptidyl Peptidase-4 Are Dissociated from Inflammation and Induced by Enzymatic DPP4 Inhibition
Elodie M. Varin, Erin E. Mulvihill, Jacqueline L. Beaudry, et al.
Cell Metabolism (2018) Vol. 29, Iss. 2, pp. 320-334.e5
Open Access | Times Cited: 119
DPP4 inhibition by sitagliptin attenuates LPS-induced lung injury in mice
Takeshi Kawasaki, Weiguo Chen, Yu Maw Htwe, et al.
AJP Lung Cellular and Molecular Physiology (2018) Vol. 315, Iss. 5, pp. L834-L845
Open Access | Times Cited: 108
Dipeptidylpeptidase 4 as a Marker of Activated Fibroblasts and a Potential Target for the Treatment of Fibrosis in Systemic Sclerosis
Alina Soare, Hermina A. Györfi, Alexandru‐Emil Matei, et al.
Arthritis & Rheumatology (2019) Vol. 72, Iss. 1, pp. 137-149
Open Access | Times Cited: 104
Microflora Disturbance during Progression of Glucose Intolerance and Effect of Sitagliptin: An Animal Study
Xinfeng Yan, Bo Feng, Peicheng Li, et al.
Journal of Diabetes Research (2016) Vol. 2016, pp. 1-10
Open Access | Times Cited: 96
DPP4 and ACE2 in Diabetes and COVID-19: Therapeutic Targets for Cardiovascular Complications?
Inés Valencia, Concepción Peiró, Óscar Lorenzo, et al.
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 95
The DPP-4 inhibitor vildagliptin impacts the gut microbiota and prevents disruption of intestinal homeostasis induced by a Western diet in mice
Marta Olivares, Audrey M. Neyrinck, Sarah A. Pötgens, et al.
Diabetologia (2018) Vol. 61, Iss. 8, pp. 1838-1848
Open Access | Times Cited: 85
Role of Dipeptidyl Peptidase 4 Inhibitors in Antidiabetic Treatment
Ruili Yin, Yongsong Xu, Xin Wang, et al.
Molecules (2022) Vol. 27, Iss. 10, pp. 3055-3055
Open Access | Times Cited: 50
Coagulation Factor Xa and Protease-Activated Receptor 2 as Novel Therapeutic Targets for Diabetic Nephropathy
Yuji Oe, Sakiko Hayashi, Tomofumi Fushima, et al.
Arteriosclerosis Thrombosis and Vascular Biology (2016) Vol. 36, Iss. 8, pp. 1525-1533
Open Access | Times Cited: 82
Antidiabetic treatment with gliptins: focus on cardiovascular effects and outcomes
Enrique Z. Fisman, Alexander Tenenbaum
Cardiovascular Diabetology (2015) Vol. 14, Iss. 1
Open Access | Times Cited: 81
Topical administration of DPP-IV inhibitors prevents retinal neurodegeneration in experimental diabetes
Cristina Hernández, Patricia Bogdanov, Cristina Solà-Adell, et al.
Diabetologia (2017) Vol. 60, Iss. 11, pp. 2285-2298
Open Access | Times Cited: 80
Mechanisms and pathways of anti‐inflammatory activity of DPP‐4 inhibitors in cardiovascular and renal protection
Katarina Tomović, Jelena Lazarević, Gordana Kocić, et al.
Medicinal Research Reviews (2018) Vol. 39, Iss. 1, pp. 404-422
Open Access | Times Cited: 73
Gut microbiota, hypertension and chronic kidney disease: Recent advances
Antonio Sircana, Franco De Michieli, Renato Parente, et al.
Pharmacological Research (2018) Vol. 144, pp. 390-408
Closed Access | Times Cited: 71
Hepatic DPP4 DNA Methylation Associates With Fatty Liver
Christian Baumeier, Sophie Saussenthaler, A Kammel, et al.
Diabetes (2016) Vol. 66, Iss. 1, pp. 25-35
Open Access | Times Cited: 68
Dipeptidyl Peptidase-4 at the Interface Between Inflammation and Metabolism
Natasha A. Trzaskalski, Evgenia Fadzeyeva, Erin E. Mulvihill
Clinical Medicine Insights Endocrinology and Diabetes (2020) Vol. 13, pp. 117955142091297-117955142091297
Open Access | Times Cited: 68
Dipeptidyl peptidase-4 is highly expressed in bronchial epithelial cells of untreated asthma and it increases cell proliferation along with fibronectin production in airway constitutive cells
Taichi Shiobara, Kazuyuki Chibana, Taiji Watanabe, et al.
Respiratory Research (2016) Vol. 17, Iss. 1
Open Access | Times Cited: 62
Plasma levels of DPP4 activity and sDPP4 are dissociated from inflammation in mice and humans
Laurie L. Baggio, Elodie M. Varin, Jacqueline A. Koehler, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 54
The Roles of Dipeptidyl Peptidase 4 (DPP4) and DPP4 Inhibitors in Different Lung Diseases: New Evidence
Tianli Zhang, Tong Xiang, Shijie Zhang, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 49
DPP4 Promotes Human Endothelial Cell Senescence and Dysfunction via the PAR2–COX-2–TP Axis and NLRP3 Inflammasome Activation
Inés Valencia, Susana Vallejo, Pilar Dongil, et al.
Hypertension (2022) Vol. 79, Iss. 7, pp. 1361-1373
Open Access | Times Cited: 29
DPP4 inhibition impairs senohemostasis to improve plaque stability in atherosclerotic mice
Allison B. Herman, Dimitrios Tsitsipatis, Carlos Anerillas, et al.
Journal of Clinical Investigation (2023) Vol. 133, Iss. 12
Open Access | Times Cited: 18
Dipeptidyl Peptidase‐4 Inhibitor Anagliptin Prevents Intracranial Aneurysm Growth by Suppressing Macrophage Infiltration and Activation
Taichi Ikedo, Manabu Minami, Hiroharu Kataoka, et al.
Journal of the American Heart Association (2017) Vol. 6, Iss. 6
Open Access | Times Cited: 60
Page 1 - Next Page

Scroll to top